Highlights

  • Zycov D likely to be available from October
  • Deemed safe for children above 12 years of age
  • 3 doses with 28 day intervals recommended

Latest news

Indian Army strikes and neutralises terror launchpads near LoC

Indian Army strikes and neutralises terror launchpads near LoC

Pak moving troops in forward areas, befitting reply given: Col Sofiya Qureshi

Pak moving troops in forward areas, befitting reply given: Col Sofiya Qureshi

Intensified security at RGIA following bomb threat email alert

Intensified security at RGIA following bomb threat email alert

Six accused in a murder case acquitted by the Supreme Court

Six accused in a murder case acquitted by the Supreme Court

Mamata Banerjee honors Indian forces and Rabindranath Tagore

Mamata Banerjee honors Indian forces and Rabindranath Tagore

Karnataka launches 2025 training scheme for young women

Karnataka launches 2025 training scheme for young women

IPL teams evacuated from Dharamshala amid rising security concerns

IPL teams evacuated from Dharamshala amid rising security concerns

Delhi government advocates safety, welfare for manual scavengers

Delhi government advocates safety, welfare for manual scavengers

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

The shot is “the world’s first and India’s indigenously developed DNA-based vaccine for Covid-19 to be administered in humans including children and adults 12 years and above.”

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Zydus Cadila's covid vaccine ZyCoV-D is set to be launched in India in October and is deemed for safe for kids above 12. This 'third-generation triple dose vaccine' could just be the answer to fill the gap of 100 crore doses required by year-end to vaccinate the vast majority of the adult population. Here is everything you need to know about this non-injecting, DNA vaccine which even children above 12 can take.

      Meet Cadila’s ZyCoV-D

      • It is the world’s first DNA vaccine to protect against Covid 19. Requires a triple dose for immunity and showcased 67% efficacy in trials. The vaccine is deemed safe for children above the age of 12.

      What kind of vaccine is it? How is it different than Covishield and Covaxin?

      • Cadila’s ZyCoV-D is a plasmid DNA vaccine that introduces a DNA sequence encoding the antigen in the body and not a weakened form of the pathogen like Covaxin.

      How does a DNA vaccine work?

      • Often referred to as the third-generation vaccines, the dose carries the genetic code of the virus that triggers the build up of immunity in one's body.
      • Zydus stated that the plasmid DNA platform is “ideally suited for dealing with Covid-19 as it can be easily adapted to deal with mutations in the virus, such as those already occurring”.

      Is a DNA vaccine being used anywhere else in the world?

      • No DNA vaccine has been widely used against any disease so far, but they are more stable and easier to store than mRNA shots (tech used by Pfizer & Moderna)
      • According to the U.S. National Library of Medicine, over 160 different DNA vaccines are currently being tested in human clinical trials in the United States. It is estimated that 62% of these trials are devoted to cancer vaccines and 33% are applied for vaccines against human immunodeficiency virus (HIV).

      How many doses does one need?

      • Unlike most other Covid-19 vaccines, which require two doses for full immunity, ZyCoV-D is administered in three doses. The vaccine is also needle-free.
      • The doses will be administered 28 days apart

      Needle-free vaccine, how does one get the dose?

      • Doses are given using a device that delivers fluid through a spring-powered jet that penetrates the skin, developed by Pharmajet’s Tropis.
      • Zydus Cadila claims this method of delivery is painless and could also reduce side effects from the jab

      Is it safe? What are the trial results showing?

      • The vaccine has been tested on almost 30,000 participants across Phase I, II and III studies, and is the first vaccine in India to be tested on 12 to 18-year-olds. Around 1,000 participants were enrolled in the adolescent age group, among whom the vaccine was found to be safe and well-tolerated, with similar findings in the adult population

      ADVERTISEMENT

      Up Next

      Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

      Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

      Global stock market indices: How the world markets performed today - 05 May 2025

      Global stock market indices: How the world markets performed today - 05 May 2025

      Indian stock market sector-wise performance today - May 5, 2025

      Indian stock market sector-wise performance today - May 5, 2025

      NSE Nifty 50: Top 5 stock losers of May 5, 2025

      NSE Nifty 50: Top 5 stock losers of May 5, 2025

      Top 5 Nifty 50 gainers today – May 5, 2025: Biggest stock moves

      Top 5 Nifty 50 gainers today – May 5, 2025: Biggest stock moves

      Global stock market indices: How the world markets performed today - 02 May 2025

      Global stock market indices: How the world markets performed today - 02 May 2025

      ADVERTISEMENT

      editorji-whatsApp

      More videos

      Indian stock market sector-wise performance today - May 2, 2025

      Indian stock market sector-wise performance today - May 2, 2025

      NSE Nifty 50: Top 5 stock losers of May 2, 2025

      NSE Nifty 50: Top 5 stock losers of May 2, 2025

      Top 5 Nifty 50 gainers today – May 2, 2025: Biggest stock moves

      Top 5 Nifty 50 gainers today – May 2, 2025: Biggest stock moves

      Majority of iPhones sold in US will be made in India in June quarter: Apple CEO

      Majority of iPhones sold in US will be made in India in June quarter: Apple CEO

      Sensex, Nifty surge in early trade on hopes of India-US trade deal, FII buying

      Sensex, Nifty surge in early trade on hopes of India-US trade deal, FII buying

      Global stock market indices: How the world markets performed today - 01 May 2025

      Global stock market indices: How the world markets performed today - 01 May 2025

      Indian stock market sector-wise performance today - May 1, 2025

      Indian stock market sector-wise performance today - May 1, 2025

      Top 5 Nifty 50 gainers today – May 1, 2025: Biggest stock moves

      Top 5 Nifty 50 gainers today – May 1, 2025: Biggest stock moves

      Global stock market indices: How the world markets performed today - 30 April 2025

      Global stock market indices: How the world markets performed today - 30 April 2025

      Indian stock market sector-wise performance today - April 30, 2025

      Indian stock market sector-wise performance today - April 30, 2025

      Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.